Big Pharma Abandon Shandong EDL Drug Market On Price Limits
This article was originally published in PharmAsia News
Executive Summary
Shandong’s drug procurement center chief said that multinational pharma has generally abandoned the province’s essential drug market for the price restrictions that put off-patent drugs in direct price competition with generics.